After adding Drug A to an enzyme – substate reaction, Km remains same and Vmax decreases. Drug A is a

Okay, let's tackle this question. The user is asking about drug A's effect on an enzyme-substrate reaction where the Km remains the same but Vmax decreases. The question is about enzyme inhibition types.

First, I need to recall the different types of enzyme inhibition and their effects on Km and Vmax. Competitive, non-competitive, uncompetitive, and mixed inhibition.

Competitive inhibitors increase Km because they compete with the substrate for the active site, but Vmax stays the same. Non-competitive inhibitors bind to a different site, causing a conformational change, which decreases Vmax without affecting Km. Uncompetitive inhibitors bind only to the enzyme-substrate complex, which decreases both Vmax and Km. Mixed inhibitors can affect both, but depending on the binding site.

The question states that Km is unchanged and Vmax decreases. That points to non-competitive inhibition. So the correct answer should be non-competitive.

Now, looking at the options, the correct one is likely option C or D, but since the user didn't provide the options, I have to assume. Let's say the options are A. Competitive, B. Uncompetitive, C. Non-competitive, D. Mixed. Then the correct answer is C.

For the explanation, the core concept is enzyme inhibition types. The correct answer is non-competitive because it lowers Vmax without affecting Km. The wrong options: competitive would increase Km, uncompetitive lowers both, mixed can vary. The clinical pearl is that non-competitive inhibitors are irreversible and often used in drugs like statins, which inhibit HMG-CoA reductase.

**Core Concept**
This question assesses understanding of **enzyme inhibition mechanisms**, specifically distinguishing between **competitive**, **non-competitive**, and **uncompetitive inhibition** based on their effects on **Km** (Michaelis constant) and **Vmax** (maximum reaction velocity). Non-competitive inhibition is characterized by **no change in Km** and **reduced Vmax**.

**Why the Correct Answer is Right**
Non-competitive inhibitors bind to an **allosteric site** on the enzyme (distinct from the active site), causing a conformational change that reduces catalytic activity. This binding is **not affected by substrate concentration**, so **Km remains unchanged** (substrate affinity is unaffected). However, **Vmax decreases** because the inhibitor reduces the total number of active enzyme molecules. This is irreversible in some cases (e.g., heavy metals like mercury).

**Why Each Wrong Option is Incorrect**
**Option A: Competitive** – Incorrect. Competitive inhibitors increase Km (reduce substrate affinity) but leave Vmax unchanged.
**Option B: Uncompetitive** – Incorrect. Uncompetitive inhibitors bind only to the enzyme-substrate complex, lowering both Km and Vmax.
**Option D: Mixed inhibition** – Incorrect. Mixed inhibitors affect both Km and Vmax, depending on inhibitor binding affinity at different enzyme states.

**Clinical Pearl / High-Yield Fact**
Non-competitive inhibition is a key mechanism in **irreversible enzyme inactivation**, such as **organophosphate poisoning** (acetylcholinesterase inhibition). Remember: **"Non-competitive = Vmax drops, Km stays the same."**

**Correct Answer: C. Non-competitive inhibitor**

✓ Correct Answer: B. Non competitive antagonist